📰 Alzn News
Alzn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alzn. Real-time updates on events, politics, business and more.
November 13, 2023
Alzamend Neuro, Inc. (ALZN.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alzamend Neuro, Inc. | Nasdaq: ALZN | Nasdaq
October 1, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Free Report) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totalling 253,400 shares, a growth of 17.3% from the August 31st total of 216,000 shares. Approximately 0.5% of the shares of the stock are sold short. Based […]
September 15, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 216,000 shares, a decrease of 60.7% from the August 15th total of 549,900 shares. Currently, 0.4% of the shares of the stock are […]
July 19, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 473,700 shares, an increase of 12.9% from the June 15th total of 419,400 shares. Currently, 1.1% of the company’s stock are short sold. Based on an […]
July 1, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Free Report) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 419,400 shares, a drop of 44.9% from the May 31st total of 761,400 shares. Currently, 0.9% of the shares of the company are short sold. Based on […]
May 5, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Rating) CEO Stephan Jackman purchased 37,000 shares of the business’s stock in a transaction on Friday, April 28th. The stock was purchased at an average cost of $0.54 per share, with a total value of $19,980.00. Following the completion of the acquisition, the chief executive officer now owns 45,500 […]
April 20, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Rating) saw a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 586,500 shares, a decrease of 18.2% from the March 15th total of 717,000 shares. Approximately 1.3% of the shares of the stock are short sold. Based on […]
April 20, 2023
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Rating) was the recipient of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 586,500 shares, a drop of 18.2% from the March 15th total of 717,000 shares. Approximately 1.3% of the company’s shares are short sold. Based […]
June 13, 2022
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Rating) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 1,690,000 shares, a growth of 79.0% from the May 15th total of 943,900 shares. Currently, 5.8% of the shares of the stock are sold short. Based on […]
June 13, 2022
Alzamend Neuro, Inc. (NASDAQ:ALZN – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 1,690,000 shares, an increase of 79.0% from the May 15th total of 943,900 shares. Based on an average daily trading volume, of 1,210,000 shares, […]